Lexaria Bioscience Corp. — Director's Dealing 2019

Apr 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2019-04-05

Reporting Person: BUNKA CHRISTOPHER (Director, Chief Executive Officer, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-05	Stock Options	$0.1	J	550000	Disposed	2019-12-23	Common Shares (550000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	6081844	Indirect
common shares	7126304	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (550000)	550000	Direct
Stock Options	$1.53	2023-05-31	Common Shares (700000)	1250000	Direct

Footnotes

F1: Cancellation of Options